These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32329134)

  • 1. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Hayashi K; Fujino N; Oka R; Nomura A; Nagata Y; Hodatsu A; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1081-7. PubMed ID: 26102305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.
    Park CH; Chung H; Kim Y; Kim JY; Min PK; Lee KA; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1619-1628. PubMed ID: 29728953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragmented QRS on electrocardiography as a predictor of myocardial scar in patients with hypertrophic cardiomyopathy.
    Ratheendran AC; Subramanian M; Bhanu DK; Prabhu MA; Kannan R; Natarajan KU; Saritha Sekhar S; Thachathodiyil R; Harikrishnan MS; Pai PG
    Acta Cardiol; 2020 Feb; 75(1):42-46. PubMed ID: 30602338
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.
    Nomsawadi V; Krittayaphong R
    Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12635. PubMed ID: 30719815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study.
    Bi X; Yang C; Song Y; Yuan J; Cui J; Hu F; Qiao S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):298. PubMed ID: 32552709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S; Sundh F; Schlegel T; Maynard C; Rück A; Wagner G; Ugander M
    J Electrocardiol; 2015; 48(4):630-6. PubMed ID: 25865909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass.
    Maanja M; Wieslander B; Schlegel TT; Bacharova L; Abu Daya H; Fridman Y; Wong TC; Schelbert EB; Ugander M
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28111363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.
    Bacharova L; Ugander M
    Ann Noninvasive Electrocardiol; 2014 Nov; 19(6):524-33. PubMed ID: 25367364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
    Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
    Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
    Chen X; Zhao T; Lu M; Yin G; Xiangli W; Jiang S; Prasad S; Zhao S
    Int J Cardiovasc Imaging; 2014 Jun; 30 Suppl 1():55-63. PubMed ID: 24723003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging.
    Krittayaphong R; Nomsawadi V; Muenkaew M; Miniphan M; Yindeengam A; Udompunturak S
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S124-32. PubMed ID: 23590032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
    Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
    Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Nagata Y; Teramoto R; Fujino N; Nomura A; Tada H; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M; Hayashi K
    Am J Cardiol; 2016 Feb; 117(3):443-9. PubMed ID: 26705881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Learning to Predict Cardiac Magnetic Resonance-Derived Left Ventricular Mass and Hypertrophy From 12-Lead ECGs.
    Khurshid S; Friedman S; Pirruccello JP; Di Achille P; Diamant N; Anderson CD; Ellinor PT; Batra P; Ho JE; Philippakis AA; Lubitz SA
    Circ Cardiovasc Imaging; 2021 Jun; 14(6):e012281. PubMed ID: 34126762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study.
    Verdecchia P; Dovellini EV; Gorini M; Gozzelino G; Lucci D; Milletich A; Maggioni AP
    Ital Heart J; 2000 Mar; 1(3):207-15. PubMed ID: 10806988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy.
    Dollar AL; Roberts WC
    Am J Med; 1989 Oct; 87(4):377-81. PubMed ID: 2529761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.